Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Eton Pharmaceuticals, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ETON
Nasdaq
2830
www.etonpharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Eton Pharmaceuticals, Inc.
H.C. Wainwright Remains Bullish on Eton Pharmaceuticals’ (ETON) Growth Strategy
- May 23rd, 2026 6:16 am
Stock Market Leaders Respect The 21-Day Line. You Should Too.
- May 22nd, 2026 8:32 am
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)
- May 19th, 2026 2:30 pm
Eton Pharmaceuticals, Inc. Just Missed EPS By 44%: Here's What Analysts Think Will Happen Next
- May 16th, 2026 8:33 am
Eton (ETON) Q1 2026 Earnings Call Transcript
- May 15th, 2026 11:21 am
Eton Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary
- May 15th, 2026 6:30 am
Eton Pharmaceuticals Inc (ETON) Q1 2026 Earnings Call Highlights: Record Sales and Strategic ...
- May 14th, 2026 11:02 pm
Eton Pharmaceuticals Q1 Earnings Call Highlights
- May 14th, 2026 6:05 pm
Eton Pharmaceuticals, Inc. (ETON) Misses Q1 Earnings Estimates
- May 14th, 2026 3:30 pm
Eton Pharmaceuticals Reports First Quarter 2026 Financial Results
- May 14th, 2026 2:05 pm
Eton Pharmaceuticals to Participate in Upcoming Investor Conferences
- May 12th, 2026 2:30 pm
Apellis Pharmaceuticals, Inc. (APLS) Tops Q1 Earnings and Revenue Estimates
- May 7th, 2026 1:25 pm
Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Lags Revenue Estimates
- May 6th, 2026 3:10 pm
Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
- May 4th, 2026 2:30 pm
Eton Pharmaceuticals (ETON) Surges 19.8%: Is This an Indication of Further Gains?
- May 4th, 2026 6:51 am
How The Hemangeol Deal Is Rewriting The Story For Eton Pharmaceuticals (ETON)
- May 3rd, 2026 7:08 am
Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution
- May 1st, 2026 4:50 am
Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700
- Apr 27th, 2026 4:50 am
Eton Pharmaceuticals (ETON) Appoints Judith M. Matthews as New CFO
- Apr 24th, 2026 1:15 pm
How The Hemangeol Deal Is Reframing The Eton Pharmaceuticals (ETON) Investment Story
- Apr 19th, 2026 5:06 am
Scroll